Last reviewed · How we verify
Miconaz oral gel
At a glance
| Generic name | Miconaz oral gel |
|---|---|
| Sponsor | Hams Hamed Abdelrahman |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- N Acetylcystene in Treatment of Radiotherapy Induced Oral Mucositis in Oral Cancer Patients (NA)
- Adjunctive Treatments for the Prevention of Radiotherapy-Induced Mucositis (NA)
- The Anti-fungal Effect of Miconazol Versus Miconazol-Loaded Chitosan Nanoparticles (PHASE1)
- Matrix Metalloproteinases Neutralizing Agents in Oral Lichen Planus (EARLY_PHASE1)
- Topical Chamomile in Preventing Chemotherapy-induced Oral Mucositis (PHASE2)
- Vitamin D Oral Gel for Prevention of Radiation Induced Oral Mucositis (PHASE2)
- Melatonin for Prevention of Radiation Induced Oral Mucositis (PHASE2)
- Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen Planus (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Miconaz oral gel CI brief — competitive landscape report
- Miconaz oral gel updates RSS · CI watch RSS
- Hams Hamed Abdelrahman portfolio CI